Press release
Chronic Hepatitis B Market Size in the 7MM is ~USD 1,500 million in 2022| DelveInsight
Key Takeaways from the Chronic Hepatitis B Market Report
* The increase in Chronic Hepatitis B Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
* As per DelveInsight analysis, the Chronic Hepatitis B Market is anticipated to witness growth at a considerable CAGR.
* The total prevalent cases of Chronic Hepatitis B in the 7MM comprised approximately 56,333,000 cases in 2022 and are projected to decrease during the forecast period
* The total prevalent cases of Chronic Hepatitis B in the United States were around 22,56,700 cases in 2022.
* The leading Chronic Hepatitis B Companies working in the market include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology and other.
* Promising Chronic Hepatitis B Pipeline Therapies in the various stages of development include RG6346, Pradefovir, VIR-3434, SBT8230, and Others.
* April 2024:- Ascletis Pharmaceuticals Co., Ltd.- Phase IIa Single Dose and Phase IIb Mutiple Dose Clinical Studies to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Subcutaneously Injected PD-L1 Antibody ASC22 in Patients With Chronic Hepatitis B.
* April 2024:- Gilead Sciences- A Phase 1a/1b Study to Evaluate the Safety and Tolerability of Repeated Doses of Nonreplicating Arenavirus Vector Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B (CHB).
* April 2024:- Hoffmann-La Roche- A Phase I Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection.
Discover which therapies are expected to grab the Chronic Hepatitis B Market Share @ Chronic Hepatitis B Market Outlook [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Hepatitis B Overview
Hepatitis B is a potentially life-threatening and one of the most common liver infections caused by the hepatitis B virus (HBV), which attacks and injures the liver. Hepatitis B is a "silent epidemic" because most people do not exhibit symptoms when newly or chronically infected. As a result, they have the potential to unintentionally infect others and prolong the slow spread of hepatitis B. If an individual suffers from a Hepatitis B virus infection that lasts more than 6 months, the infection becomes chronic. Chronic Hepatitis B increases the risk of developing liver failure, liver cancer, or cirrhosis. The risk of developing a Chronic hepatitis B infection is also directly related to the age at which one first becomes exposed to the hepatitis B virus. Males are more prone to develop Chronic hepatitis B.
Chronic Hepatitis B Epidemiology Insights
As the market is derived using the patient-based model, the Chronic Hepatitis B epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of Chronic Hepatitis B, Total Diagnosed Prevalent Cases of Chronic Hepatitis B, Gender-specific Diagnosed Prevalent Cases of Chronic Hepatitis B, Age-specific Diagnosed Prevalent Cases of Chronic Hepatitis B, Type-specific Diagnosed Prevalent Cases of Chronic Hepatitis B, and Total Treated Cases of Chronic Hepatitis B in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2019 to 2032.
Download the report to understand which factors are driving Chronic Hepatitis B Epidemiology trends @ Chronic Hepatitis B Epidemiological Insights [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Hepatitis B Drugs Market
The Chronic Hepatitis B Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Chronic Hepatitis B signaling in Chronic Hepatitis B are likely to uncover new therapeutic targets and further expand treatment options for patients.
Chronic Hepatitis B Treatment Market Landscape
The Chronic Hepatitis B treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Chronic Hepatitis B has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To know more about Chronic Hepatitis B treatment guidelines, visit @ Chronic Hepatitis B Treatment Market Landscape [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Hepatitis B Market Outlook
The report's outlook on the Chronic Hepatitis B market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Chronic Hepatitis B therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Chronic Hepatitis B drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Chronic Hepatitis B market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Chronic Hepatitis B Drugs Uptake
The drug chapter of the Chronic Hepatitis B report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Chronic Hepatitis B.
Major Chronic Hepatitis B Companies
Several Chronic Hepatitis B Companies working in the market include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, and other.
Learn more about the FDA-approved drugs for Chronic Hepatitis B @ Drugs for Chronic Hepatitis B Treatment [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Chronic Hepatitis B Market Research Report
* Coverage- 7MM
* Chronic Hepatitis B Companies- Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, and other.
* Chronic Hepatitis B Pipeline Therapies- RG6346, Pradefovir, VIR-3434, SBT8230, and Others.
* Chronic Hepatitis B Market Dynamics: Chronic Hepatitis B Market Drivers and Barriers
* Chronic Hepatitis B Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Chronic Hepatitis B Drugs in development @ Chronic Hepatitis B Clinical Trials Assessment [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Report Introduction
3. Chronic Hepatitis B Market Overview at a Glance
4. Executive Summary of Chronic Hepatitis B
5. Chronic Hepatitis B Epidemiology and Market Methodology
6. Disease Background and Overview
7. Diagnosis of Hepatitis B Infection
8. Current Chronic Hepatitis B Treatment Practices
9. Chronic Hepatitis B Epidemiology and Patient Population
10. Chronic Hepatitis B Patient Journey
11. Key Endpoints in Chronic Hepatitis B Clinical Trials
12. Marketed Chronic Hepatitis B Therapies
13. Emerging Chronic Hepatitis B Therapies
14. Discontinued Chronic Hepatitis B Drugs
15. Chronic Hepatitis B: The 7MM Analysis
16. Chronic Hepatitis B Market Access and Reimbursement
17. Chronic Hepatitis B KOL Views
18. SWOT Analysis
19. Chronic Hepatitis B Unmet Needs
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chronic-hepatitis-b-market-size-in-the-7mm-is-usd-1500-million-in-2022-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Hepatitis B Market Size in the 7MM is ~USD 1,500 million in 2022| DelveInsight here
News-ID: 3468984 • Views: …
More Releases from ABNewswire
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Hepatitis
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Key Influencer in the Hepatitis B Virus (HBV) Market 2025: Rising Hepatitis B In …
Which drivers are expected to have the greatest impact on the over the hepatitis b virus (hbv) market's growth?
The escalated incidence rates of hepatitis B infection are anticipated to contribute significantly to the future expansion of the hepatitis B virus market. Hepatitis B is a liver-related infection that is triggered by the hepatitis B virus (HBV), and can be avoided through vaccination. The surge in hepatitis B infection rates could…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
